Literature DB >> 28380251

Apremilast and suicidality - a retrospective analysis of three large databases: the FAERS, EudraVigilance and a large single-centre US patient population.

P P Vakharia1, K A Orrell1, D Lee1, S M Rangel1, E Lund1, A E Laumann1, D P West1, B Nardone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28380251     DOI： 10.1111/jdv.14256

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

2.  Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.

Authors:  Matheus Vieira; Solène Buffier; Mathieu Vautier; Alexandre Le Joncour; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Laurence Bouillet; Estibaliz Lazaro; Stéphane Barete; Laurent Misery; Delphine Gobert; Tiphaine Goulenok; Olivier Fain; Karim Sacre; Pascal Sève; Patrice Cacoub; Cloé Comarmond; David Saadoun
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.